Literature DB >> 28357488

Study on inter-ethnic human differences in bioactivation and detoxification of estragole using physiologically based kinetic modeling.

Jia Ning1, Jochem Louisse2, Bert Spenkelink2, Sebastiaan Wesseling2, Ivonne M C M Rietjens2.   

Abstract

Considering the rapid developments in food safety in the past decade in China, it is of importance to obtain insight into what extent safety and risk assessments of chemicals performed for the Caucasian population apply to the Chinese population. The aim of the present study was to determine physiologically based kinetic (PBK) modeling-based predictions for differences between Chinese and Caucasians in terms of metabolic bioactivation and detoxification of the food-borne genotoxic carcinogen estragole. The PBK models were defined based on kinetic constants for hepatic metabolism derived from in vitro incubations using liver fractions of the two ethnic groups, and used to evaluate the inter-ethnic differences in metabolic activation and detoxification of estragole. The models predicted that at realistic dietary intake levels, only 0.02% of the dose was converted to the ultimate carcinogenic metabolite 1'-sulfooxyestragole in Chinese subjects, whereas this amounted to 0.09% of the dose in Caucasian subjects. Detoxification of 1'-hydroxyestragole, mainly via conversion to 1'-oxoestragole, was similar within the two ethnic groups. The 4.5-fold variation in formation of the ultimate carcinogenic metabolite of estragole accompanied by similar rates of detoxification may indicate a lower risk of estragole for the Chinese population at similar levels of exposure. The study provides a proof of principle for how PBK modeling can identify differences in ethnic sensitivity and provide a more refined risk assessment for a specific ethnic group for a compound of concern.

Entities:  

Keywords:  Caucasian; Chinese; Estragole; Inter-ethnic difference; Physiologically based kinetic modeling

Mesh:

Substances:

Year:  2017        PMID: 28357488      PMCID: PMC5562778          DOI: 10.1007/s00204-017-1941-x

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  36 in total

1.  Human cytochrome p450 enzyme specificity for the bioactivation of estragole and related alkenylbenzenes.

Authors:  Suzanne M F Jeurissen; Ans Punt; Marelle G Boersma; Jan J P Bogaards; Yiannis C Fiamegos; Benoit Schilter; Peter J van Bladeren; Nicole H P Cnubben; Ivonne M C M Rietjens
Journal:  Chem Res Toxicol       Date:  2007-04-04       Impact factor: 3.739

2.  Tandem mass spectrometry analysis of N2-(trans-Isoestragol-3'-yl)-2'-deoxyguanosine as a strategy to study species differences in sulfotransferase conversion of the proximate carcinogen 1'-hydroxyestragole.

Authors:  Ans Punt; Thierry Delatour; Gabriele Scholz; Benoît Schilter; Peter J van Bladeren; Ivonne M C M Rietjens
Journal:  Chem Res Toxicol       Date:  2007-06-23       Impact factor: 3.739

3.  Same drug, different dosing: differences in dosing for drugs approved in the United States, Europe, and Japan.

Authors:  Henry J Malinowski; Agnes Westelinck; Junko Sato; Ting Ong
Journal:  J Clin Pharmacol       Date:  2008-06-04       Impact factor: 3.126

4.  Metabolic capabilities of cytochrome P450 enzymes in Chinese liver microsomes compared with those in Caucasian liver microsomes.

Authors:  Junling Yang; Minxia M He; Wei Niu; Steven A Wrighton; Li Li; Yang Liu; Chuan Li
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

5.  In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin.

Authors:  M B Fisher; K Campanale; B L Ackermann; M VandenBranden; S A Wrighton
Journal:  Drug Metab Dispos       Date:  2000-05       Impact factor: 3.922

6.  A quantitative property-property relationship (QPPR) approach to estimate in vitro tissue-blood partition coefficients of organic chemicals in rats and humans.

Authors:  J DeJongh; H J Verhaar; J L Hermens
Journal:  Arch Toxicol       Date:  1997       Impact factor: 5.153

7.  Inter-species comparison of 7-hydroxycoumarin glucuronidation and sulfation in liver S9 fractions.

Authors:  Qing Wang; Cindy Ye; Richard Jia; Albert J Owen; Ismael J Hidalgo; Jibin Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Jan-Feb       Impact factor: 2.416

8.  Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole.

Authors:  E C Miller; A B Swanson; D H Phillips; T L Fletcher; A Liem; J A Miller
Journal:  Cancer Res       Date:  1983-03       Impact factor: 12.701

9.  Metabolism of estragole in rat and mouse and influence of dose size on excretion of the proximate carcinogen 1'-hydroxyestragole.

Authors:  A Anthony; J Caldwell; A J Hutt; R L Smith
Journal:  Food Chem Toxicol       Date:  1987-11       Impact factor: 6.023

10.  Mode of action based risk assessment of the botanical food-borne alkenylbenzene apiol from parsley using physiologically based kinetic (PBK) modelling and read-across from safrole.

Authors:  Abdalmajeed M Alajlouni; Amer J Al Malahmeh; Reiko Kiwamoto; Sebastiaan Wesseling; Ans E M F Soffers; Ala A A Al-Subeihi; Jacques Vervoort; Ivonne M C M Rietjens
Journal:  Food Chem Toxicol       Date:  2016-01-27       Impact factor: 6.023

View more
  2 in total

1.  In vitro-in silico-based prediction of inter-individual and inter-ethnic variations in the dose-dependent cardiotoxicity of R- and S-methadone in humans.

Authors:  Miaoying Shi; Yumeng Dong; Hans Bouwmeester; Ivonne M C M Rietjens; Marije Strikwold
Journal:  Arch Toxicol       Date:  2022-05-23       Impact factor: 6.168

2.  Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone.

Authors:  Miaoying Shi; Hans Bouwmeester; Ivonne M C M Rietjens; Marije Strikwold
Journal:  Arch Toxicol       Date:  2020-05-04       Impact factor: 5.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.